Proof-of-concept Study of Blood Markers of Tumor Dissemination in Patients with Versus Without Intestinal Polyps

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Dec 5, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how certain blood markers can help understand the spread of tumor cells in patients with intestinal polyps. The researchers believe that these polyps might release substances that allow tumor cells to travel in the body. By studying these markers, they hope to improve how doctors monitor patients and create more targeted treatment strategies for those at risk of colorectal cancer.

To take part in this study, participants need to be between the ages of 65 and 74 and must be scheduled for a colonoscopy, which is a test to examine the colon. They should also have health insurance. Some people, like those who are pregnant, have a history of cancer, or are involved in other clinical studies, won't be eligible. If you choose to participate, you'll be helping researchers learn more about the potential risks associated with intestinal polyps and how to manage them better in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient to be examined by colonoscopy
• • The patient must be a member or beneficiary of a health insurance plan
• Exclusion Criteria:
• • The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study
• • The subject signals their opposition to participate in the study
• • It is impossible to give the subject informed information
• • The patient is under safeguard of justice or state guardianship
• • Patient pregnant or breastfeeding
• • History of proven cancerous disease
• • Patient followed for a chronic inflammatory bowel disease

Trial Officials